1. Home
  2. BGMS vs BMRA Comparison

BGMS vs BMRA Comparison

Compare BGMS & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGMS

Bio Green Med Solution Inc.

N/A

Current Price

$0.97

Market Cap

5.8M

Sector

N/A

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.16

Market Cap

6.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGMS
BMRA
Founded
1996
1971
Country
Malaysia
United States
Employees
19
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
6.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
BGMS
BMRA
Price
$0.97
$2.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
167.5K
21.7K
Earning Date
05-14-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$80,482.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.87
52 Week High
$6.70
$4.60

Technical Indicators

Market Signals
Indicator
BGMS
BMRA
Relative Strength Index (RSI) 43.63 50.96
Support Level $0.90 $2.11
Resistance Level $1.12 $2.23
Average True Range (ATR) 0.10 0.07
MACD -0.01 0.00
Stochastic Oscillator 7.68 65.79

Price Performance

Historical Comparison
BGMS
BMRA

About BGMS Bio Green Med Solution Inc.

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: